Pluristem Signs Collaboration Agreement With …
Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific HAIFA, Israel, July 09, 2018 - Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that it has entered into a strategic collaboration
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
NASDAQ Global Data Agreement, Agreement, Nasdaq, NASDAQ OMX Global Subscriber Agreement, NASDAQ OMX Global Subscriber Agreement Instructions, Data, MICROCHIP TECHNOLOGY TO ACQUIRE MICROSEMI, PRACTICAL GUIDE TO SUPPLIER DEVELOPMENT, Global tax strategy, Investment Outlook, Global, Grifols reinforces its Hospital Division